We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+2.84%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$37.8B
AUM Growth
+$858M
Cap. Flow
+$54.1M
Cap. Flow %
0.14%
Top 10 Hldgs %
5.01%
Holding
2,954
New
116
Increased
1,159
Reduced
1,473
Closed
125

Top Buys

Rank Stock Value
1
IT icon
Gartner
IT
+$57.5M
2
ALGN icon
Align Technology
ALGN
+$53.5M
3
DXC icon
DXC Technology
DXC
+$51.9M
4
ANSS
Ansys
ANSS
+$46.1M
5
EG icon
Everest Group
EG
+$34.5M

Sector Composition

Rank Sector Weight
1 Technology 13.9%
2 Financials 12.99%
3 Healthcare 12.28%
4 Industrials 11.03%
5 Consumer Discretionary 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EDD
1576
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$375M
$2.12M 0.01%
267,701
+15,136
+6% +$121K
ALR
1577
DELISTED
Alere Inc
ALR
$2.12M 0.01%
42,292
+9,989
+31% +$481K
AGCO icon
1578
AGCO
AGCO
$8.41B
$2.12M 0.01%
31,476
-22,839
-42% -$1.46M
KSM
1579
DELISTED
DWS Strategic Municipal Income Trust
KSM
$2.11M 0.01%
169,496
+14,033
+9% +$177K
MSGS icon
1580
Madison Square Garden
MSGS
$9.59B
$2.11M 0.01%
15,022
+656
+5% +$92.8K
AG icon
1581
First Majestic Silver
AG
$7.52B
$2.1M 0.01%
253,267
-31,072
-11% -$261K
MAGN
1582
Magnera Corp
MAGN
$493M
$2.1M 0.01%
8,286
-1,689
-17% -$430K
BCV
1583
Bancroft Fund
BCV
$130M
$2.1M 0.01%
97,300
-12,233
-11% -$262K
LCII icon
1584
LCI Industries
LCII
$2.59B
$2.1M 0.01%
20,531
-2,824
-12% -$271K
ARNC.PRB
1585
DELISTED
Arconic Inc.
ARNC.PRB
$2.1M 0.01%
+58,695
New +$2.44M
PANW icon
1586
Palo Alto Networks
PANW
$256B
$2.1M 0.01%
94,068
-4,254
-4% -$85.9K
FPRX
1587
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$2.1M 0.01%
69,643
+12,234
+21% +$382K
HMN icon
1588
Horace Mann Educators
HMN
$2.11B
$2.09M 0.01%
55,416
-10,372
-16% -$400K
ETG
1589
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.74B
$2.08M 0.01%
121,708
+15,627
+15% +$259K
STMP
1590
DELISTED
Stamps.com, Inc.
STMP
$2.08M 0.01%
13,412
-236
-2% -$29.7K
USAC icon
1591
USA Compression Partners
USAC
$3.69B
$2.07M 0.01%
126,741
+9,787
+8% +$161K
SNV
1592
DELISTED
Synovus
SNV
$2.07M 0.01%
46,765
-20,347
-30% -$855K
CMC icon
1593
Commercial Metals
CMC
$7.53B
$2.07M 0.01%
106,362
-45,806
-30% -$849K
SNY icon
1594
Sanofi
SNY
$107B
$2.06M 0.01%
43,017
+19,675
+84% +$940K
LNTH icon
1595
Lantheus
LNTH
$6.51B
$2.06M 0.01%
116,660
+104,645
+871% +$1.54M
ADEA icon
1596
Adeia
ADEA
$2.55B
$2.05M 0.01%
260,419
-13,170
-5% -$111K
ACOR
1597
DELISTED
Acorda Therapeutics
ACOR
$2.05M 0.01%
868
+162
+23% +$321K
SKM icon
1598
SK Telecom
SKM
$11.4B
$2.05M 0.01%
48,484
+10,838
+29% +$435K
ZTR
1599
Virtus Total Return Fund
ZTR
$337M
$2.05M 0.01%
162,300
+58,986
+57% +$728K
SU icon
1600
Suncor Energy
SU
$77.7B
$2.05M 0.01%
70,080
-1,200
-2% -$36.9K

Similar funds

Guggenheim Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Guggenheim Capital held 2,954 positions worth $37.8B, up 2.3% from $36.9B the previous quarter. Its ten largest holdings account for 5% of the portfolio.

Guggenheim Capital's Q2 2017 filing shows 116 new, 1,159 increased, 1,473 reduced and 125 closed positions. Its largest new stake was DXC Technology: 781,396 shares worth $51.9M. The largest sale was Yahoo Inc, an estimated $55.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Guggenheim Capital's largest Q2 2017 buy was DXC Technology: 781,396 shares worth $51.9M.
  • Guggenheim Capital added most to Gartner in Q2 2017, an estimated $57.5M increase.
  • Guggenheim Capital's biggest Q2 2017 reduction was Teradata, cutting an estimated $40.2M.
  • Guggenheim Capital fully exited Yahoo Inc in Q2 2017, selling an estimated $55.8M.
  • Guggenheim Capital's ten largest holdings make up 5% of its $37.8B portfolio in Q2 2017.
  • Guggenheim Capital opened 116 new positions and closed 125 in Q2 2017.
  • Guggenheim Capital's portfolio value rose 2.3% quarter-over-quarter to $37.8B.

Based on Guggenheim Capital's 13F filing for Q2 2017, filed 14 Aug 2017.